Ruptura esplénica después de terapia anticoagulante en un paciente con antecedente de COVID-19: reporte de caso

López-Almanza, Perla Ximena; Martínez-Garza, Pablo A.; González-Hermosillo-Cornejo, Daniel; Montalvo-Domínguez, Gerardo A.; Álvarez-Hernández, Diego A.

doi:10.24875/CIRU.22000006

Ruptura esplénica después de terapia anticoagulante en un paciente con antecedente de COVID-19: reporte de caso

Journal

Cirugía y Cirujanos

ISSN

0009-7411

Date Issued

2023

Author(s)

López-Almanza, Perla Ximena

Facultad de Ciencias de la Salud - CampCM

Martínez-Garza, Pablo A.

González-Hermosillo-Cornejo, Daniel

Montalvo-Domínguez, Gerardo A.

Álvarez-Hernández, Diego A.

Type

text::journal::journal article

DOI

10.24875/CIRU.22000006

URL

https://scripta.up.edu.mx/handle/20.500.12552/4948

Abstract

We present the case of a 75-year-old man with a history of COVID-19 and splenic infarct treated with enoxaparin, who presented with intense abdominal pain and tomographic findings of free peri-splenic fluid and a hyperdense image in the spleen. An emergency laparotomy was performed, with findings of a splenic rupture at the vascular hilum. Spontaneous splenic rupture is a rare and fatal entity that should be suspected in a patient with history of COVID-19 who presents with acute abdominal pain after the administration of heparin.